10-Q quarterly report · filed Nov 5, 2026

Privia Health Group, Inc. (PRVA) Q3 2026 10-Q Quarterly Report

Short answer

Privia Health Group, Inc. (PRVA) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $657M (up 13.2% year over year) with net income of $13M.

Q3 2026 key financials · XBRL

Revenue
$657M
+13.2% YoY · +3.8% QoQ
Net income
$13M
+96.6% YoY · +49.1% QoQ
Operating margin
3.1%
EPS (diluted)
$0.10
+66.7% YoY · +42.9% QoQ

Source: XBRL data from the Privia Health Group, Inc. (PRVA) Q3 2026 10-Q on SEC EDGAR. USD.

Privia Health Group, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $657.0M, up 13.2% YoY from $580.4M, driven by FFS patient care growth
  • Care Margin 21.0% vs 21.6% YoY, while Adjusted EBITDA Margin 29.4% vs 30.5%
  • Best line FFS patient care: $433.1M, up 22.8%; weakest shared savings: $68.8M, down 13.9%
  • Cash $446.3M; operating cash flow turned negative at $19.4M vs $35.9M provided YoY
  • Near-term liquidity adequate; headwind from shared-savings timing and settlements

Risk Factors

  • No material changes to risk factors disclosed in the latest Annual Report
  • Key carried-forward risks not specified in the quarterly filing

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Privia Health Group, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.